RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa
European Patent
16762623.3
Filed on 2017-10-11
16762623.3
Filed on 2017-10-11
RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa
Canada
2979229
Filed on 2016-03-11
2979229
Filed on 2016-03-11
RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa
Australia
2016228751
Filed on 2016-03-11
2016228751
Filed on 2016-03-11
Methods of Treatment Using Sterculic Acid
United Kingdom
11731200.9
Filed on 2011-06-24
11731200.9
Filed on 2011-06-24
Methods of Treatment Using Sterculic Acid
France
11731200.9
Filed on 2011-06-24
11731200.9
Filed on 2011-06-24
Methods of Treatment Using Sterculic Acid
Germany
11731200.9
Filed on 2011-06-24
11731200.9
Filed on 2011-06-24
Selective Estrogen-receptor Modulators (SERMs) Confer Protection Against Photoreceptor Degeneration
Patent Cooperation Treaty
PCT/US2017/046359
Filed on 2017-08-10
PCT/US2017/046359
Filed on 2017-08-10
Method of Reducing Adverse Effects in a Cancer Patient Undergoing Treatment with a MEK Inhibitor
Ireland
13792162.3
Filed on 2015-06-02
13792162.3
Filed on 2015-06-02
Method of Reducing Adverse Effects in a Cancer Patient Undergoing Treatment with a MEK Inhibitor
United Kingdom
13792162.3
Filed on 2015-06-02
13792162.3
Filed on 2015-06-02